@ExTINGUISHTrial

The ExTINGUISH Trial for NMDAR Encephalitis, a NeuroNEXT Clinical Trial Network study sponsored by NIH/NINDS 👉Enrolling Now

[@ExTINGUISHTrial @extinguishtrial]

📣What is NMDA Receptor Encephalitis, and Why is the ExTINGUISH Trial so important? Watch and Share with your network 👇🏼- You may just help someone get to the correct diagnosis 🧠🔥 #Awareness #KnowledgeIsPower #Neurology #Encephalitis #Neurotwitter https://t.co/QgrN3DQE2H

[Alberto Vogrig @Vogrig_Alberto]

Curious about the latest in autoimmune neurology? Houston, August 2026—AAN’s conference brings the people and ideas you don’t want to miss. #AAN #Neurology

[Stacey Clardy MD PhD @StaceyLClardy]

📣 Registration and Abstracts now open for the AAN Autoimmune Neurology Conference!! #AANANC

Friday, August 7 - Saturday, August 8, 2026
Marriott Marquis Houston,
and live online.

-Early registration rates end June 18

-Advance registration thru July 16

🔥 Don’t miss it! 🧠

[Stacey Clardy MD PhD @StaceyLClardy]

Very cool story (and updated science to accompany it!) about an environmental exposure causing neurologic autoimmunity 👇 🧠 🎙️

@GreenJournal #NeurologyPodcast

[Stacey Clardy MD PhD @StaceyLClardy]

Mark your Calendar now 👇

It only happens once every two years,
and for only two days:

The @AANmember Autoimmune Neurology Conference

August 7-8, 2026 in Houston, TX

🤫 P.S. - The lineup is AMAZING 🧠 🔥

[@ExTINGUISHTrial @extinguishtrial]

Early symptoms of NMDAR encephalitis often include psychiatric or behavioral changes before neurological signs appear.

Clinical research is helping define optimal treatments. Learn more about the ExTINGUISH Trial.
#Neurology #ExtinguishTrial #Encephalitis #NMDAR

[José María Cabrera @josemariacm_]

First patient at @hospitalclinic with anti-NMDA receptor encephalitis randomized and first infusion completed in the @extinguishtrial.
Proud work by @neuroimmuclinic 🙌

[@ExTINGUISHTrial @extinguishtrial]

NMDAR Encephalitis can happen any season, any time of year… which is why @extinguishtrial teams are always ready, on call, for all new NMDAR Encephalitis patients in the US, the Netherlands, and Spain.

[@ExTINGUISHTrial @extinguishtrial]

Check out this article about the @ExTINGUISHtrial … and see if you detect anything unusual about the podcast “demo” on the article ??? 👂🎙️

@NMatch2026

[Neurology Journal @GreenJournal]

@StaceyLClardy Read the related article in Neurology Open Access: https://t.co/RxgF4K2lJJ

[Neurology Journal @GreenJournal]

@StaceyLClardy Read the related article in Neurology Open Access: https://t.co/RxgF4K2lJJ

[Practical Neurology @PracticalNeurol]

🧠 New in Practical Neurology:
Paraneoplastic KLHL11 antibody encephalitis presenting with progressive tinnitus, hearing loss, and cerebellar ataxia.
KLHL11-IgG - strongly linked to testicular germ cell tumours - shows a distinctive “sparkles” pattern on immunofluorescence 🔬
Early recognition is key to prevent irreversible neuronal injury.
📄 Mahmoud et al., Pract Neurol 2025;25:443–447
🔗 https://t.co/s0W40TEIDf
#Neuroimmunology #AutoimmuneEncephalitis #Paraneoplastic #KLHL11 #Neurology #MedTwitter

[Andreu Vilaseca @andreuvilaseca7]

What if antibodies in autoimmune encephalitis could teach us how the brain works?🧬🧠
In anti-NMDAR encephalitis, immune attacks on NMDA receptors reveal their key role in memory, attention, and circuit reinforcement.
Featured in @GreenJournal.
#Neurology #NMDAR

[Trends in Molecular Medicine @TrendsMolecMed]

ONLINE NOW: Anti-N-methyl-d-aspartate receptor encephalitis: insights and future treatment directions https://t.co/V7f6hd91QN

[@ExTINGUISHTrial @extinguishtrial]

Still climbing. ⛰️

Still raising awareness. 🧠

Still enrolling in this critical clinical trial to bring patients with #NMDAR Encephalitis the evidence they so desperately need and deserve. 🤝

https://t.co/UASAbC66vn

[@ExTINGUISHTrial @extinguishtrial]

"Stop staring at mountains. Climb them instead, yes, it's a harder process but it will lead you to a better view"
Philipp Reiter

No choice but to climb the mountain when recovering from Encephalitis… but there is an incredible community here to support you 🤝 @extinguishtrial

[@ExTINGUISHTrial @extinguishtrial]

@Mark_Heslin @AaronLBerkowitz @caseyalbin … and there is (finally) an actively enrolling clinical trial for NMDAR Encephalitis patients!

https://t.co/QUa8qrnwsX

[José María Cabrera @josemariacm_]

At the #ECTRIMS2025 Pre-Day in Barcelona! Fascinating talk by Thaís Armangué on HSV encephalitis and NMDAR — a truly relevant and thought-provoking topic at the intersection of infection and autoimmunity.

[@ExTINGUISHTrial @extinguishtrial]

Always pushing ahead- The @extinguishtrial, still enrolling, still pushing for answers, evidence, and better care for patients with NMDAR Encephalitis

[The Sumaira Foundation @TheSumairaFDN]

🩷🧡💛 It’s been one month since our SLC Patient Day + we're still smiling!

Read the summary, view the photo gallery and relive our most impactful day yet here: https://t.co/h7Iu3yOOg6

Thank you @StaceyLClardy, @UofUNeurology and @extinguishtrial for your collaboration 🌺

[Stacey Clardy MD PhD @StaceyLClardy]

🧠🎙️ @NINDSdirector provides a comprehensive update - covering everything we need to know in 2025 - for all Neurology Clinicians & Neuroscience Researchers -
Have a listen to this 2-part @GreenJournal podcast 👇

@AANmember
@SfNtweets
@TheNewANA1
@NMatch2026
@AUPN_leaders